Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential IPV/OPV schedules versus OPV alone in healthy Chinese infants
2015-005188-17Phase 4
- Sponsor
- Sanofi
- Start
- Nov 2015
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of inactivated poliovirus vaccine and poliovirus vaccine in poliomyelitis (3 arms), sponsored by Sanofi. Primary endpoint: Seroprotection after primary vaccination series.
02
Drugs
inactivated poliovirus vaccinepoliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on 2015-005188-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005188-17.